ROSIELLO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 406
NA - Nord America 328
AS - Asia 281
SA - Sud America 10
AF - Africa 1
Totale 1.026
Nazione #
US - Stati Uniti d'America 324
SE - Svezia 218
CN - Cina 152
SG - Singapore 105
IT - Italia 65
RU - Federazione Russa 49
FI - Finlandia 24
NL - Olanda 19
DE - Germania 12
IN - India 11
PE - Perù 9
HK - Hong Kong 7
GB - Regno Unito 6
CA - Canada 4
BE - Belgio 3
IE - Irlanda 3
CZ - Repubblica Ceca 2
ID - Indonesia 2
RO - Romania 2
BG - Bulgaria 1
BR - Brasile 1
EG - Egitto 1
JP - Giappone 1
LT - Lituania 1
PL - Polonia 1
PS - Palestinian Territory 1
TR - Turchia 1
VN - Vietnam 1
Totale 1.026
Città #
Shanghai 81
Singapore 79
Lawrence 50
Princeton 50
New York 38
Ashburn 37
Boardman 35
Milan 22
Helsinki 21
Moscow 17
Guangzhou 8
Lima 8
Dronten 6
Hong Kong 6
Rome 6
Shenzhen 6
Washington 6
Amsterdam 5
Beijing 5
Pune 5
Borås 4
Jiaxing 4
Brussels 3
Dublin 3
Hyderabad 3
Lappeenranta 3
Santa Clara 3
Seattle 3
Toronto 3
Turin 3
Camponogara 2
Cancello e Arnone 2
Cortona 2
Dallas 2
Florence 2
Hangzhou 2
London 2
Osio Sotto 2
Oude Meer 2
Padova 2
Pisa 2
Taizhou 2
Ufa 2
Xi'an 2
Yogyakarta 2
Al Matariyah 1
Andover 1
Atlanta 1
Brookline 1
Buffalo 1
Busto Garolfo 1
Casoria 1
Council Bluffs 1
Crotone 1
Ferrara 1
Frankfurt am Main 1
Friesland 1
Gunzenhausen 1
Haining 1
Ho Chi Minh City 1
Los Angeles 1
Ludhiana 1
Manchester 1
Mountain View 1
Mumbai 1
Munich 1
Noto 1
Pero 1
Predosa 1
Qingdao 1
Quanzhou 1
Redwood City 1
Rockville 1
San Antonio 1
Sector 3 1
São Paulo 1
Temecula 1
Vaprio d'Adda 1
Varna 1
Winnipeg 1
Yiwu 1
Yorii 1
Totale 590
Nome #
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 33
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 33
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 32
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 31
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 30
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 29
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 28
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 25
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 25
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 24
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 23
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 23
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 23
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 22
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 22
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 21
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 21
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 20
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 20
Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium 20
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 18
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 18
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 17
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 17
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract 17
Effect of Age on Cancer-specific Mortality in Patients with Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis across Disease Stages 17
Bladder cancer incidence rates and trends in young adults aged 20-39 years 16
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 16
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 16
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 15
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 15
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 15
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 15
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 14
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 14
External beam radiation therapy improves survival in elderly metastatic prostate cancer patients with low PSA 14
Contemporary Rates and Predictors of Open Conversion During Minimally Invasive Radical Prostatectomy for Nonmetastatic Prostate Cancer 14
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer 14
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 14
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 14
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer 14
The key role of levator ani thickness for early urinary continence recovery in patients undergoing robot-assisted radical prostatectomy: A multi-institutional study 14
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 13
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 13
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 13
The effect of systemic chemotherapy on survival in patients with localized, regional, or metastatic adenocarcinoma of the urinary bladder 13
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 12
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 12
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical nephroureterectomy 12
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 12
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 11
Erratum: Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010 (European urology oncology PII: S2588-9311(23)00237-7) 11
Pulmonary lesion after surgery for renal cancer: progression or new primary? 11
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 11
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 11
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 11
Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas 11
Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion 11
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 11
Small renal masses with tumor size 0 to 2 cm: A SEER-based study and validation of NCCN guidelines 11
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 10
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma 10
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 10
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 10
The impact of sex and age on distribution of metastases in patients with renal cell carcinoma 9
Re: Stamatio Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920–9 8
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 8
Totale 1.118
Categoria #
all - tutte 16.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 41 0 0 4 0 0 0
2021/202233 0 2 2 13 2 1 0 0 1 0 1 11
2022/2023358 131 84 35 5 6 42 6 29 15 0 1 4
2023/2024334 20 20 29 21 20 52 8 61 7 9 17 70
2024/2025348 111 42 54 45 31 65 0 0 0 0 0 0
Totale 1.118